Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Shares Sold by Alliancebernstein L.P.

Alliancebernstein L.P. reduced its stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 4.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,820 shares of the company’s stock after selling 3,350 shares during the period. Alliancebernstein L.P.’s holdings in Aveanna Healthcare were worth $310,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in AVAH. Geode Capital Management LLC raised its holdings in shares of Aveanna Healthcare by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock valued at $7,287,000 after buying an additional 63,190 shares during the period. State Street Corp raised its stake in shares of Aveanna Healthcare by 0.9% during the third quarter. State Street Corp now owns 1,039,920 shares of the company’s stock valued at $5,408,000 after purchasing an additional 9,446 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in shares of Aveanna Healthcare by 0.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company’s stock valued at $2,133,000 after purchasing an additional 4,047 shares during the period. First Eagle Investment Management LLC acquired a new stake in Aveanna Healthcare during the 4th quarter valued at $1,992,000. Finally, Arrowstreet Capital Limited Partnership increased its stake in Aveanna Healthcare by 15.4% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 282,876 shares of the company’s stock worth $1,293,000 after buying an additional 37,801 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Stock Performance

Shares of AVAH stock opened at $4.22 on Tuesday. The stock has a market capitalization of $823.30 million, a price-to-earnings ratio of -12.41 and a beta of 1.99. Aveanna Healthcare Holdings Inc. has a one year low of $2.15 and a one year high of $6.19. The company’s 50-day simple moving average is $4.76 and its 200-day simple moving average is $4.91.

Insiders Place Their Bets

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total transaction of $31,415.40. Following the sale, the insider now directly owns 1,451,598 shares of the company’s stock, valued at approximately $8,172,496.74. This represents a 0.38 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold a total of 67,412 shares of company stock valued at $372,142 in the last quarter. Insiders own 7.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on AVAH. UBS Group raised their target price on Aveanna Healthcare from $3.20 to $4.50 and gave the company a “sell” rating in a research note on Friday, March 14th. Truist Financial cut their target price on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, April 11th.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.